Johnson & Johnson (JNJ) Current Assets (2009 - 2026)

Johnson & Johnson (JNJ) posted Current Assets of $59.2 billion for Q1 2026, up 6.38% sequentially from $55.6 billion in Q4 2025, and down 17.3% YoY from $71.6 billion in Q1 2025.

Johnson & Johnson (JNJ) Current Assets (2009 - 2026) Analysis & Trends

Johnson & Johnson (JNJ) has 18 years of Current Assets data on file, last reported at $59.2 billion in Q1 2026.

  • Quarterly Current Assets fell 17.3% year-over-year to $59.2 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $59.2 billion (down 17.3% YoY) and the FY2025 annual result came in at $55.6 billion, changed 0.48% from the prior year.
  • Current Assets grew to $59.2 billion in Q1 2026 per JNJ's latest filing, from $55.6 billion in the prior quarter.
  • The five-year high for Current Assets was $71.6 billion in Q1 2025, with the low at $53.2 billion in Q3 2024.
  • Average Current Assets over 5 years is $58.7 billion, with a median of $57.4 billion recorded in 2024.
  • Year-over-year, Current Assets decreased 17.68% in 2023 and increased 25.52% in 2025.
  • Johnson & Johnson's Current Assets stood at $65.2 billion in 2022, then slipped by 18.0% to $53.5 billion in 2023, then advanced by 4.48% to $55.9 billion in 2024, then slipped by 0.48% to $55.6 billion in 2025, then gained by 6.38% to $59.2 billion in 2026.
  • Business Quant data shows JNJ's Current Assets at $59.2 billion in Q1 2026, $55.6 billion in Q4 2025, and $54.6 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 54.84 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 59.17 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 33.53 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn 29.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 35.02 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 31.48 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 18.64 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 42.82 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Biogen 30.87 Bn 26.59 Bn 1.82 Bn 9.19 Bn

Historic Data

Download Data
DateValue
Mar 29, 2026 59.17 Bn
Dec 28, 2025 55.62 Bn
Sep 28, 2025 54.61 Bn
Jun 29, 2025 54.50 Bn
Mar 30, 2025 71.55 Bn
Dec 29, 2024 55.89 Bn
Sep 29, 2024 53.25 Bn
Jun 30, 2024 57.82 Bn
Mar 31, 2024 57.00 Bn
Dec 31, 2023 53.50 Bn
Oct 1, 2023 53.70 Bn
Jul 2, 2023 60.57 Bn
Apr 2, 2023 64.39 Bn
Jan 1, 2023 55.29 Bn
Oct 2, 2022 65.24 Bn
Jul 3, 2022 63.85 Bn
Apr 3, 2022 60.42 Bn
Jan 2, 2022 60.98 Bn
Oct 3, 2021 59.89 Bn
Jul 4, 2021 53.77 Bn